German regulator sees no new risks from Bayer’s Xarelto

FRANKFURT (Reuters) – The number of reported side effects linked to Bayer’s stroke prevention pill Xarelto is below worrisome levels, a German drugs regulator said, responding to a media report highlighting risks from taking the blood thinning drug. “There is no new risk situation,” a spokesman for Germany’s Federal Institute for Drugs and Medical Devices (BfArM) said on Monday. German magazine Der Spiegel reported over the weekend that Bayer faced a growing number of reports of bleeding in patients taking Xarelto, citing BfArM figures. Bayer shares had declined 1. …